Literature DB >> 9216960

Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.

J A Simoneau1, D E Kelley.   

Abstract

The insulin resistance of skeletal muscle in glucose-tolerant obese individuals is associated with reduced activity of oxidative enzymes and a disproportionate increase in activity of glycolytic enzymes. Because non-insulin-dependent diabetes mellitus (NIDDM) is a disorder characterized by even more severe insulin resistance of skeletal muscle and because many individuals with NIDDM are obese, the present study was undertaken to examine whether decreased oxidative and increased glycolytic enzyme activities are also present in NIDDM. Percutaneous biopsy of vatus lateralis muscle was obtained in eight lean (L) and eight obese (O) nondiabetic subjects and in eight obese NIDDM subjects and was assayed for marker enzymes of the glycolytic [phosphofructokinase, glyceraldehyde phosphate dehydrogenase, hexokinase (HK)] and oxidative pathways [citrate synthase (CS), cytochrome-c oxidase], as well as for a glycogenolytic enzyme (glycogen phosphorylase) and a marker of anaerobic ATP resynthesis (creatine kinase). Insulin sensitivity was measured by using the euglycemic clamp technique. Activity for glycolytic enzymes (phosphofructokinase, glyceraldehye phosphate dehydrogenase, HK) was highest in subjects with subjects with NIDDM, following the order of NIDDM > O > L, whereas maximum velocity for oxidative enzymes (CS, cytochrome-c oxidase) was lowest in subjects with NIDDM. The ratio between glycolytic and oxidative enzyme activities within skeletal muscle correlated negatively with insulin sensitivity. The HK/CS ratio had the strongest correlation (r = -0.60, P < 0.01) with insulin sensitivity. In summary, an imbalance between glycolytic and oxidative enzyme capacities is present in NIDDM subjects and is more severe than in obese or lean glucose-tolerant subjects. The altered ratio between glycolytic and oxidative enzyme activities found in skeletal muscle of individuals with NIDDM suggests that a dysregulation between mitochondrial oxidative capacity and capacity for glycolysis is an important component of the expression of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216960     DOI: 10.1152/jappl.1997.83.1.166

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  133 in total

Review 1.  Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 2.  Type 2 diabetes mellitus and cardiovascular exercise performance.

Authors:  Judith G Regensteiner
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

4.  Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements.

Authors:  Ian R Lanza; Sumit Bhagra; K Sreekumaran Nair; John D Port
Journal:  J Magn Reson Imaging       Date:  2011-11       Impact factor: 4.813

Review 5.  Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state.

Authors:  Luc J C van Loon; Bret H Goodpaster
Journal:  Pflugers Arch       Date:  2005-09-10       Impact factor: 3.657

6.  Inverse relationship between exercise economy and oxidative capacity in muscle.

Authors:  Gary R Hunter; Marcas M Bamman; D Enette Larson-Meyer; Denis R Joanisse; John P McCarthy; Tamilane E Blaudeau; Bradley R Newcomer
Journal:  Eur J Appl Physiol       Date:  2005-06-15       Impact factor: 3.078

Review 7.  Skeletal muscle fat oxidation: timing and flexibility are everything.

Authors:  David E Kelley
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

8.  Comprehensive association testing of common mitochondrial DNA variation in metabolic disease.

Authors:  Richa Saxena; Paul I W de Bakker; Karyn Singer; Vamsi Mootha; Noel Burtt; Joel N Hirschhorn; Daniel Gaudet; Bo Isomaa; Mark J Daly; Leif Groop; Kristin G Ardlie; David Altshuler
Journal:  Am J Hum Genet       Date:  2006-05-24       Impact factor: 11.025

Review 9.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

10.  Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in cultured myotubes.

Authors:  Daniel O Espinoza; Laszlo G Boros; Sarah Crunkhorn; Hiral Gami; Mary-Elizabeth Patti
Journal:  FASEB J       Date:  2009-11-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.